SCHEMBL13507749

SCHEMBL13507749

Cn1c2cc(-c3cc4ccccc4c4ccccc34)ccc2c2c3ccccc3c3c4ccc(-c5cc6ccccc6c6ccccc56)cc4n(C)c3c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.42
▸ HSD17B10 Q99714 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ LIMK1 P53667 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ERBB2 P04626 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ FYN P06241 1/20 0.37
▸ MAOA P21397 1/20 0.37
▸ ACHE P22303 1/20 0.37
▸ AHR P35869 1/20 0.37
▸ BRD9 Q9H8M2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13507567 0.88 L3MBTL1 (0.40) CYP11B1HSD17B10ALDH1A1HPGDTSHR
SCHEMBL13507978 0.87 LIMK1 (0.44) HSD17B10LIMK1MAOBKDM4EMAPT
SCHEMBL13507467 0.85 KDM4E (0.40) HSD17B10ALDH1A1HPGDTSHRMAPK1
SCHEMBL13507734 0.82 LIMK1 (0.44) CYP11B1L3MBTL1LIMK1MAOBKDM4E
SCHEMBL13508170 0.82 CA12 (0.43) LIMK1MAOBKDM4EMAOARET
SCHEMBL13507850 0.81 LIMK1 (0.46) CYP11B1LIMK1MAOBKDM4EMAPT
SCHEMBL13507867 0.80 MAOB (0.57) HSD17B10HPGDL3MBTL1LIMK1MAOB
SCHEMBL13507635 0.79 MET (0.41) CYP11B1LIMK1MAOBKDM4ECYP1A2
SCHEMBL13508164 0.78 LIMK1 (0.39) LIMK1MAOBKDM4EMAPTGABRP
SCHEMBL13507633 0.78 MAOB (0.50) CYP11B1HSD17B10ALDH1A1LIMK1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 CYP11B1 720/4885HSD17B10 1287/4885ALDH1A1 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback